The makers of Zenzedi – a prescription medication prescribed to people with ADHD or narcolepsy – have issued a voluntary recall of their 30 mg tablets after a pharmacist found tablets of an antihistamine inside a Zanzedi bottle.

Patients who take carbinoxamine instead of Zenzedi® will experience undertreatment of their symptoms, which may result in functional impairment and an increased risk of accidents or injury.

To date, Azurity has not received any reports of serious adverse events related to this recall.

Zenzedi® 30 mg tablets can be identified by light yellow hexagonal tablet debossed with “30” on one side and “MIA” on the other side and distributed in a white bottle with black writing and “30 mg” highlighted yellow.

Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product. An adverse event may also be reported to Azurity via email at aereports@azurity.com.